| Predictors of subjective and objective quality of life in outpatients with schizophrenia K Yamauchi, H Aki, M Tomotake, JI Iga, S Numata, I Motoki, Y Izaki, ... Psychiatry and clinical neurosciences 62 (4), 404-411, 2008 | 154 | 2008 |
| Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms S Numata, S Ueno, J Iga, K Yamauchi, S Hongwei, K Ohta, S Kinouchi, ... Neuroscience letters 401 (1-2), 1-5, 2006 | 148 | 2006 |
| Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS) SY Tayoshi, S Sumitani, K Taniguchi, S Shibuya-Tayoshi, S Numata, J Iga, ... Schizophrenia research 108 (1-3), 69-77, 2009 | 144 | 2009 |
| Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder J Iga, S Ueno, K Yamauchi, S Numata, S Tayoshi-Shibuya, S Kinouchi, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (3), 658-663, 2007 | 141 | 2007 |
| Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis M Kato, H Hori, T Inoue, J Iga, M Iwata, T Inagaki, K Shinohara, H Imai, ... Molecular psychiatry 26 (1), 118-133, 2021 | 139 | 2021 |
| GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study SY Tayoshi, M Nakataki, S Sumitani, K Taniguchi, S Shibuya-Tayoshi, ... Schizophrenia research 117 (1), 83-91, 2010 | 135 | 2010 |
| Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression J Iga, S Ueno, K Yamauchi, S Numata, S Kinouchi, S Tayoshi-Shibuya, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (3), 628-632, 2007 | 131 | 2007 |
| The Val66Met polymorphism of the brain‐derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients JI Iga, SI Ueno, K Yamauchi, S Numata, S Tayoshi‐Shibuya, S Kinouchi, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144 …, 2007 | 111 | 2007 |
| Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia H Aki, M Tomotake, Y Kaneda, J Iga, S Kinouchi, S Shibuya-Tayoshi, ... Psychiatry Research 158 (1), 19-25, 2008 | 107 | 2008 |
| DNA methylation signatures of peripheral leukocytes in schizophrenia M Kinoshita, S Numata, A Tajima, S Shimodera, S Ono, A Imamura, J Iga, ... Neuromolecular medicine 15, 95-101, 2013 | 101 | 2013 |
| Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation S Numata, K Ishii, A Tajima, J Iga, M Kinoshita, S Watanabe, H Umehara, ... Epigenetics 10 (2), 135-141, 2015 | 97 | 2015 |
| DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease Y Ozaki, Y Yoshino, K Yamazaki, T Sao, Y Mori, S Ochi, T Yoshida, T Mori, ... Journal of psychiatric research 92, 74-80, 2017 | 86 | 2017 |
| Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine J Iga, S Ueno, K Yamauchi, I Motoki, S Tayoshi, K Ohta, H Song, K Morita, ... Neuroscience letters 389 (1), 12-16, 2005 | 81 | 2005 |
| Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population S Numata, S Ueno, J Iga, H Song, M Nakataki, SY Tayoshi, S Sumitani, ... Journal of psychiatric research 43 (1), 7-12, 2008 | 66 | 2008 |
| DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies Y Funahashi, Y Yoshino, K Yamazaki, Y Mori, T Mori, Y Ozaki, T Sao, ... Psychiatry and Clinical Neurosciences 71 (1), 28-35, 2017 | 61 | 2017 |
| Gene expression and association analysis of LIM (PDLIM5) in major depression J Iga, S Ueno, K Yamauchi, S Numata, I Motoki, S Tayoshi, S Kinouchi, ... Neuroscience letters 400 (3), 203-207, 2006 | 52 | 2006 |
| Subjective and objective measures of quality of life have different predictors for people with schizophrenia M Tomotake, Y Kaneda, JI Iga, S Kinouchi, S Tayoshi, I Motoki, S Sumitani, ... Psychological Reports 99 (2), 477-487, 2006 | 50 | 2006 |
| Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder J Iga, S Watanabe, S Numata, H Umehara, A Nishi, M Kinoshita, ... Human Psychopharmacology: Clinical and Experimental 31 (3), 193-199, 2016 | 46 | 2016 |
| Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for … Y Takaesu, K Watanabe, S Numata, M Iwata, N Kudo, S Oishi, T Takizawa, ... Psychiatry and clinical neurosciences 73 (10), 642-648, 2019 | 45 | 2019 |
| Elevated mRNA expression and low methylation of SNCA in Japanese Alzheimer’s disease subjects Y Yoshino, T Mori, T Yoshida, K Yamazaki, Y Ozaki, T Sao, Y Funahashi, ... Journal of Alzheimer’s Disease 54 (4), 1349-1357, 2016 | 45 | 2016 |